Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
MIC (functional) | = 32 ug ml-1 | Minimum inhibitory concentration against Trichophyton mentagrophytes | ChEMBL. | 14741262 |
MIC (functional) | = 32 ug ml-1 | Minimum inhibitory concentration against Trichophyton ajelloi | ChEMBL. | 14741262 |
MIC (functional) | = 32 ug ml-1 | Minimum inhibitory concentration Microsporum gypseum | ChEMBL. | 14741262 |
MIC (functional) | = 32 ug ml-1 | Minimum inhibitory concentration against Microsporum nanum | ChEMBL. | 14741262 |
MIC (functional) | = 64 ug ml-1 | Minimum inhibitory concentration against Microsporum cookei | ChEMBL. | 14741262 |
MIC (functional) | = 256 ug ml-1 | Minimum inhibitory concentration Staphylococcus aureus ATCC 29213 | ChEMBL. | 14741262 |
MIC (functional) | > 512 ug ml-1 | Minimum inhibitory concentration against Candida albicans ATCC 10231 | ChEMBL. | 14741262 |
MIC (functional) | > 512 ug ml-1 | Minimum inhibitory concentration against Streptococcus faecalis ATCC 29212 | ChEMBL. | 14741262 |
MIC (functional) | > 512 ug ml-1 | Minimum inhibitory concentration against Pseudomonas aeruginosae ATCC 27853 | ChEMBL. | 14741262 |
MIC (functional) | = 512 ug ml-1 | Minimum inhibitory concentration against Escherichia coli ATCC 25853 | ChEMBL. | 14741262 |
MIC (functional) | >= 512 ug ml-1 | Minimum inhibitory concentration against Aspergillus niger | ChEMBL. | 14741262 |
MIC (functional) | >= 512 ug ml-1 | Minimum inhibitory concentration against Aspergillus flavus | ChEMBL. | 14741262 |
MIC (functional) | > 512 ug ml-1 | Minimum inhibitory concentration against Candida albicans ATCC 10231 | ChEMBL. | 14741262 |
MIC (functional) | = 512 ug ml-1 | Minimum inhibitory concentration against Escherichia coli ATCC 25853 | ChEMBL. | 14741262 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.